Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (53)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kelada, S. N.
Right arrow Articles by Khoury, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelada, S. N.
Right arrow Articles by Khoury, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 154, No. 1 : 1-13
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health


HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEWS

{delta}-Aminolevulinic Acid Dehydratase Genotype and Lead Toxicity: A HuGE Review

Samir N. Kelada1,4, Erin Shelton2, Rachel B. Kaufmann3 and Muin J. Khoury1

1 Office of Genetics and Disease Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
2 Department of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, MI.
3 Lead Poisoning Prevention Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
4 Current address: Department of Environmental Health, School of Public Health and Community Medicine, University of Washington, Seattle, WA.

ABSTRACT

The ALAD gene (chromosome 9q34) codes for {delta}-aminolevulinic acid dehydratase (ALAD) (E.C. 4.2.1.24). ALAD catalyzes the second step of heme synthesis and is polymorphic. The ALAD G177C polymorphism yields two codominant alleles, ALAD-1 and ALAD-2, and it has been implicated in susceptibility to lead toxicity. Genotype frequencies vary by geography and race. The rarer ALAD-2 allele has been associated with high blood lead levels and has been thought to increase the risk of lead toxicity by generating a protein that binds lead more tightly than the ALAD-1 protein. Other evidence suggests that ALAD-2 may confer resistance to the harmful effects of lead by sequestering lead, making it unavailable for pathophysiologic participation. Recent studies have shown that individuals who are homozygous for the ALAD-1 allele have higher cortical bone lead levels; this implies that they may have a greater body lead burden and may be at higher risk of the long-term effects of lead. Individuals exposed to lead in occupational settings have been the most frequent subjects of study. Genotype selection bias may limit inferences from these studies. No firm evidence exists for an association between ALAD genotype and susceptibility to lead toxicity at background exposure levels; therefore, population testing for the ALAD polymorphism is not justified.

ALAD; aminolevulinic acid; epidemiology; genetic predisposition to disease; genetics; lead; lead poisoning; porphobilinogen synthase

Abbreviations: ALAD, aminolevulinic acid dehydratase; DMSA, dimercaptosuccinic acid; HFE, hereditary hemochromatosis gene; NHANES, National Health and Nutrition Examination Survey; SD, standard deviation; VDR, vitamin D receptor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
A. Shaik and K Jamil
A study on the ALAD gene polymorphisms associated with lead exposure
Toxicology and Industrial Health, August 1, 2008; 24(7): 501 - 506.
[Abstract] [PDF]


Home page
Am J EpidemiolHome page
P. Rajan, K. T. Kelsey, J. D. Schwartz, D. C. Bellinger, J. Weuve, D. Sparrow, A. Spiro III, T. J. Smith, H. Nie, H. Hu, et al.
Lead Burden and Psychiatric Symptoms and the Modifying Influence of the {delta}-Aminolevulinic Acid Dehydratase (ALAD) Polymorphism: The VA Normative Aging Study
Am. J. Epidemiol., December 15, 2007; 166(12): 1400 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Rajaraman, P. A. Stewart, J. M. Samet, B. S. Schwartz, M. S. Linet, S. H. Zahm, N. Rothman, M. Yeager, H. A. Fine, P. M. Black, et al.
Lead, Genetic Susceptibility, and Risk of Adult Brain Tumors
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2514 - 2520.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
J Weuve, K T Kelsey, J Schwartz, D Bellinger, R O Wright, P Rajan, A Spiro III, D Sparrow, A Aro, and H Hu
Delta-aminolevulinic acid dehydratase polymorphism and the relation between low level lead exposure and the Mini-Mental Status Examination in older men: the Normative Aging Study
Occup. Environ. Med., November 1, 2006; 63(11): 746 - 753.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
S-E Chia, H J Zhou, E Yap, M T Tham, N-V Dong, N T Hong Tu, and K-S Chia
Association of renal function and delta-aminolevulinic acid dehydratase polymorphism among Vietnamese and Singapore workers exposed to inorganic lead.
Occup. Environ. Med., March 1, 2006; 63(3): 180 - 186.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
S-E Chia, E Yap, and K-S Chia
Can {delta}-aminolevulinic acid dehydratase 2 allele exert certain protective measures against the neurotoxic effects of lead?
Occup. Environ. Med., August 1, 2004; 61(8): 720 - 720.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. Little, M. J. Khoury, L. Bradley, M. Clyne, M. Gwinn, B. Lin, M.-L. Lindegren, and P. Yoon
The Human Genome Project Is Complete. How Do We Develop a Handle for the Pump?
Am. J. Epidemiol., April 15, 2003; 157(8): 667 - 673.
[Full Text] [PDF]


Home page
NEJMHome page
P. A. Marsden
Increased Body Lead Burden -- Cause or Consequence of Chronic Renal Insufficiency?
N. Engl. J. Med., January 23, 2003; 348(4): 345 - 347.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.